Literature DB >> 32616495

APOL1 Nephropathy: From Genetics to Clinical Applications.

David J Friedman1, Martin R Pollak1.   

Abstract

Rates of many types of severe kidney disease are much higher in Black individuals than most other ethnic groups. Much of this disparity can now be attributed to genetic variants in the apoL1 (APOL1) gene found only in individuals with recent African ancestry. These variants greatly increase rates of hypertension-associated ESKD, FSGS, HIV-associated nephropathy, and other forms of nondiabetic kidney disease. We discuss the population genetics of APOL1 risk variants and the clinical spectrum of APOL1 nephropathy. We then consider clinical issues that arise for the practicing nephrologist caring for the patient who may have APOL1 kidney disease.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  APOL1; APOL1 protein; African Americans; Apolipoprotein L1; Focal Segmental; Genetics; Glomerulosclerosis; HIV-Associated Nephropathy; Kidney Genomics Series; Population; chronic kidney disease; diabetes mellitus; genetic kidney disease; human; hypertension; kidney

Mesh:

Substances:

Year:  2020        PMID: 32616495      PMCID: PMC7863644          DOI: 10.2215/CJN.15161219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  77 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion.

Authors:  Daniel Granado; Daria Müller; Vanessa Krausel; Etty Kruzel-Davila; Christian Schuberth; Melanie Eschborn; Roland Wedlich-Söldner; Karl Skorecki; Hermann Pavenstädt; Ulf Michgehl; Thomas Weide
Journal:  J Am Soc Nephrol       Date:  2017-07-10       Impact factor: 10.121

3.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

4.  APOL1 Genotype and Renal Function of Black Living Donors.

Authors:  Mona D Doshi; Mariella Ortigosa-Goggins; Amit X Garg; Lihua Li; Emilio D Poggio; Cheryl A Winkler; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-16       Impact factor: 10.121

5.  Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

Authors:  B I Freedman; B A Julian; S O Pastan; A K Israni; D Schladt; M D Gautreaux; V Hauptfeld; R A Bray; H M Gebel; A D Kirk; R S Gaston; J Rogers; A C Farney; G Orlando; R J Stratta; S Mohan; L Ma; C D Langefeld; P J Hicks; N D Palmer; P L Adams; A Palanisamy; A M Reeves-Daniel; J Divers
Journal:  Am J Transplant       Date:  2015-03-24       Impact factor: 8.086

6.  Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.

Authors:  Jeffrey B Kopp; Cheryl A Winkler; Xiongce Zhao; Milena K Radeva; Jennifer J Gassman; Vivette D D'Agati; Cynthia C Nast; Changli Wei; Jochen Reiser; Lisa M Guay-Woodford; Martin R Pollak; Friedhelm Hildebrandt; Marva Moxey-Mims; Debbie S Gipson; Howard Trachtman; Aaron L Friedman; Frederick J Kaskel
Journal:  J Am Soc Nephrol       Date:  2015-01-08       Impact factor: 10.121

7.  An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.

Authors:  Catherine C Robertson; Christopher E Gillies; Rosemary K B Putler; Derek Ng; Kimberly J Reidy; Brendan Crawford; Matthew G Sampson
Journal:  Nephrol Dial Transplant       Date:  2017-12-01       Impact factor: 5.992

Review 8.  Protective association between JC polyoma viruria and kidney disease.

Authors:  Jasmin Divers; Carl D Langefeld; Douglas S Lyles; Lijun Ma; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 3.416

9.  APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.

Authors:  Derek K Ng; Catherine C Robertson; Robert P Woroniecki; Sophie Limou; Christopher E Gillies; Kimberly J Reidy; Cheryl A Winkler; Sangeeta Hingorani; Keisha L Gibson; Rebecca Hjorten; Christine B Sethna; Jeffrey B Kopp; Marva Moxey-Mims; Susan L Furth; Bradley A Warady; Matthias Kretzler; John R Sedor; Frederick J Kaskel; Matthew G Sampson
Journal:  Nephrol Dial Transplant       Date:  2017-06-01       Impact factor: 5.992

10.  Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection.

Authors:  Marie Samanovic; Maria Pilar Molina-Portela; Anne-Danielle C Chessler; Barbara A Burleigh; Jayne Raper
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

View more
  29 in total

1.  APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program.

Authors:  Adriana M Hung; Shailja C Shah; Alexander G Bick; Zhihong Yu; Hua-Chang Chen; Christine M Hunt; Frank Wendt; Otis Wilson; Robert A Greevy; Cecilia P Chung; Ayako Suzuki; Yuk-Lam Ho; Elvis Akwo; Renato Polimanti; Jin Zhou; Peter Reaven; Philip S Tsao; J Michael Gaziano; Jennifer E Huffman; Jacob Joseph; Shiuh-Wen Luoh; Sudha Iyengar; Kyong-Mi Chang; Juan P Casas; Michael E Matheny; Christopher J O'Donnell; Kelly Cho; Ran Tao; Katalin Susztak; Cassianne Robinson-Cohen; Sony Tuteja; Edward D Siew
Journal:  JAMA Intern Med       Date:  2022-04-01       Impact factor: 21.873

2.  GWAS in Mice Maps Susceptibility to HIV-Associated Nephropathy to the Ssbp2 Locus.

Authors:  Nicholas J Steers; Yask Gupta; Vivette D D'Agati; Tze Y Lim; Natalia DeMaria; Anna Mo; Judy Liang; Kelsey O Stevens; Dina F Ahram; Wan Yee Lam; Mihai Gagea; Lalitha Nagarajan; Simone Sanna-Cherchi; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2021-12-10       Impact factor: 10.121

3.  Validating a Computable Phenotype for Nephrotic Syndrome in Children and Adults Using PCORnet Data.

Authors:  Andrea L Oliverio; Dorota Marchel; Jonathan P Troost; Isabelle Ayoub; Salem Almaani; Jessica Greco; Cheryl L Tran; Michelle R Denburg; Michael Matheny; Chad Dorn; Susan F Massengill; Hailey Desmond; Debbie S Gipson; Laura H Mariani
Journal:  Kidney360       Date:  2021-09-27

Review 4.  A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology.

Authors:  Abraham W Aron; Neera K Dahl; Whitney Besse
Journal:  Kidney360       Date:  2022-07-08

5.  Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.

Authors:  Rita L McGill; Milda R Saunders; Alexandra L Hayward; Arlene B Chapman
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-20       Impact factor: 10.614

Review 6.  Kidney disease and APOL1.

Authors:  Aminu Abba Yusuf; Melanie A Govender; Jean-Tristan Brandenburg; Cheryl A Winkler
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

7.  COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation.

Authors:  David J Friedman
Journal:  J Am Soc Nephrol       Date:  2020-12-07       Impact factor: 10.121

Review 8.  The quagmire of race, genetic ancestry, and health disparities.

Authors:  Giorgio Sirugo; Sarah A Tishkoff; Scott M Williams
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

9.  JAK inhibitor blocks COVID-19 cytokine-induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids.

Authors:  Sarah E Nystrom; Guojie Li; Somenath Datta; Karen L Soldano; Daniel Silas; Astrid Weins; Gentzon Hall; David B Thomas; Opeyemi A Olabisi
Journal:  JCI Insight       Date:  2022-06-08

10.  [Kidney damage in COVID-19].

Authors:  Stéphane Burtey; Marion Sallée
Journal:  Nephrol Ther       Date:  2021-06-23       Impact factor: 0.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.